WallStreetZenWallStreetZen

NASDAQ: DNTH
Dianthus Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for DNTH

Based on 4 analysts offering 12 month price targets for Dianthus Therapeutics Inc.
Min Forecast
$22.00-13.59%
Avg Forecast
$28.50+11.94%
Max Forecast
$44.00+72.82%

Should I buy or sell DNTH stock?

Based on 4 analysts offering ratings for Dianthus Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DNTH stock forecasts and price targets.

DNTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-15
lockedlocked$00.00+00.00%2024-01-26
lockedlocked$00.00+00.00%2023-12-26
lockedlocked$00.00+00.00%2023-09-28

1 of 1

Forecast return on equity

Is DNTH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is DNTH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DNTH revenue forecast

What is DNTH's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$3.1M+237.88%
Avg 2 year Forecast
$3.2M+251.19%
Avg 3 year Forecast
$3.4M+265.58%
DNTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DNTH revenue growth forecast

How is DNTH forecast to perform vs Biotechnology companies and vs the US market?
Company
54.02%
Industry
45.3%
Market
10.84%
DNTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DNTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DNTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DNTH$25.46$28.50+11.94%Strong Buy
ENGN$16.25$31.00+90.77%Buy
RENB$2.61N/AN/A
ADCT$4.63$8.50+83.59%Buy
HRTX$2.56$4.00+56.56%Buy

Dianthus Therapeutics Stock Forecast FAQ

Is Dianthus Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: DNTH) stock is to Strong Buy DNTH stock.

Out of 4 analysts, 2 (50%) are recommending DNTH as a Strong Buy, 2 (50%) are recommending DNTH as a Buy, 0 (0%) are recommending DNTH as a Hold, 0 (0%) are recommending DNTH as a Sell, and 0 (0%) are recommending DNTH as a Strong Sell.

If you're new to stock investing, here's how to buy Dianthus Therapeutics stock.

What is DNTH's revenue growth forecast for 2024-2026?

(NASDAQ: DNTH) Dianthus Therapeutics's forecast annual revenue growth rate of 54.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Dianthus Therapeutics's revenue in 2024 is $924,000.On average, 3 Wall Street analysts forecast DNTH's revenue for 2024 to be $46,261,053, with the lowest DNTH revenue forecast at $29,635,524, and the highest DNTH revenue forecast at $54,766,448. On average, 3 Wall Street analysts forecast DNTH's revenue for 2025 to be $48,083,638, with the lowest DNTH revenue forecast at $29,635,524, and the highest DNTH revenue forecast at $59,863,758.

In 2026, DNTH is forecast to generate $50,054,400 in revenue, with the lowest revenue forecast at $29,635,524 and the highest revenue forecast at $65,790,863.

What is DNTH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DNTH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DNTH's Price Target?

According to 4 Wall Street analysts that have issued a 1 year DNTH price target, the average DNTH price target is $28.50, with the highest DNTH stock price forecast at $44.00 and the lowest DNTH stock price forecast at $22.00.

On average, Wall Street analysts predict that Dianthus Therapeutics's share price could reach $28.50 by Feb 15, 2025. The average Dianthus Therapeutics stock price prediction forecasts a potential upside of 11.94% from the current DNTH share price of $25.46.

What is DNTH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DNTH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.